Form 4: Corbus Pharmaceuticals CEO Yuval Cohen Reports Stock and Option Awards

CEO Yuval Cohen reports the acquisition of restricted stock units and stock options in Corbus Pharmaceuticals.

Summary

• On January 31, 2025, Yuval Cohen, CEO of Corbus Pharmaceuticals Holdings, Inc., was granted 68,100 restricted stock units (RSUs) that will be settled in shares of common stock.
• These RSUs will vest 25% annually, starting on January 31, 2026.
• In the event of termination without cause after the first vesting date, a pro-rata portion of the RSUs will accelerate vesting.
• Cohen also acquired 228,800 stock options with an exercise price of $9.79, vesting 25% on January 31, 2026, and the remaining 75% in equal monthly installments over 36 months starting February 28, 2026.
• Following these transactions, Cohen beneficially owns 145,321 shares of common stock, including 142,047 unvested RSUs, and 228,800 stock options.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which are generally viewed neutrally to positively as they align management interests with shareholders.

Positives

• The grant of RSUs and stock options to the CEO aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.

Industry Context

This is a standard practice for incentivizing and retaining key executives in publicly traded companies, particularly in the pharmaceutical industry where long-term research and development efforts are crucial.

Comparison to Industry Standards

• Granting stock options and RSUs to executives is a common practice in the pharmaceutical industry.
• Companies like Amgen, Gilead Sciences, and Biogen routinely use equity-based compensation to align executive interests with shareholder value.
• The vesting schedules and terms are generally in line with industry norms, promoting long-term commitment and performance.

Stakeholder Impact

• Shareholders: Aligns CEO's interests with long-term company performance.
• Employees: May boost morale by demonstrating confidence in leadership.
• CEO: Provides incentive for continued service and performance.

Key Dates